1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 10 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2001The effect of folic acid deficiency and MTHFR C677T polymorphism on chromosome damage in human lymphocytes in vitroCrott, J.; Mashiyama, S.; Ames, B.; Fenech, M.
2009Associations between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with TamoxifenSchroth, W.; Goetz, M.; Hamann, U.; Fasching, P.; Schmidt, M.; Winter, S.; Fritz, P.; Simon, W.; Suman, V.; Ames, M.; Safgren, S.; Kuffel, M.; Ulmer, H.; Bolander, J.; Strick, R.; Beckmann, M.; Koelbl, H.; Weinshilboum, R.; Ingle, J.; Eichelbaum, M.; et al.
2008Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexilineDavies, B.; Herbert, M.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
2002Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transportersGlaeser, H.; Drescher, S.; Van der Kuip, H.; Behrens, C.; Geick, A.; Burk, O.; Dent, J.; Somogyi, A.; von Richter, O.; Griese, E.; Eichelbaum, M.; Fromm, M.
2008Propafenone for the prevention of atrial tachyarrhythmias after cardiac surgery: a randomized, double-blind placebo-controlled trialMorike, K.; Kivisto, K.; Schaeffeler, E.; Jagle, C.; Igel, S.; Drescher, S.; Fux, R.; Marx, C.; Hofmann, U.; Engel, C.; Wagner, F.; Delabar, U.; Meisner, C.; Bail, D.; Bohm, J.; Gleiter, C.; Ziemer, G.; Rein, J.; Hellberg, K.; Eichelbaum, M.; et al.
1996The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.Capon, D.; Bochner, F.; Kerry, N.; Mikus, G.; Danz, C.; Somogyi, A.
1996Pharmacokinetic evaluation of proguanil: a probe phenotyping drug for the mephenytoin hydroxylase polymorphism.Somogyi, A.; Reinhard, H.; Bochner, F.
2008Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study GroupSchwab, M.; Zanger, U.; Marx, C.; Schaeffeler, E.; Klein, K.; Dippon, J.; Kerb, R.; Blievernicht, J.; Fischer, J.; Hofmann, U.; Bokemeyer, C.; Eichelbaum, M.
2010CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: Expanded polymorphism coverage improves risk stratificationSchroth, W.; Hamann, U.; Fasching, P.; Dauser, S.; Winter, S.; Eichelbaum, M.; Schwab, M.; Brauch, H.
2006The effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human lymphocytes in vivoKirsch-Volders, M.; Mateuca, R.; Roelants, M.; Tremp, A.; Zeiger, E.; Bonassi, S.; Holland, N.; Chang, W.; Aka, P.; DeBoeck, M.; Godderis, L.; Haufroid, V.; Ishikawa, H.; Laffon, B.; Marcos, R.; Migliore, L.; Norppa, H.; Teixeira, J.; Zijno, A.; Fenech, M.

Discover